Kadmon, the biotechnology company founded by ImClone's Sam Waksal, is preparing to file confidentially for an initial public offering, sources say.» Read More
Oct 22- Eli Lilly& Co reported sharply better-than-expected quarterly earnings due to cost controls and sales of new treatments for diabetes and cancer, keeping the U.S. drugmaker on track for its planned return to growth this year. "We are encouraged by the combination of Lilly's new product cycle coupled with expense management, which we see driving healthy...
Some of the names on the move ahead of the open.
U.S. stock futures were higher this morning, with the market trying to avoid its first three-session losing streak of October.
Three Dow components and dozens of other companies will report earnings Thursday morning.
The $100 million Dementia Discovery Fund is unusual in focusing on a single difficult-to-treat disorder and in bringing together both industry and government. The initiative was announced by British health minister Jeremy Hunt in March, following a Group of Eight nations conference in 2013 that set a goal of finding a cure or effective treatment for...
The "Halftime Report" traders give their top trades.
So far the earnings season has been lackluster, and some high-profile warnings have already given investors pause.
Jim Cramer arms investors with the inside mindset of how hedge funds and mutual funds will play this market slowdown.
Oct 16- Hong Kong- based drugmaker Hutchison China MediTech Ltd has filed for an initial public offering in the United States, according to a regulatory filing. In the corresponding period last year, the listing of 10 Chinese companies in the United States had raised over $3.5 billion, according to Thomson Reuters data. The company, which listed on the London Stock...
LONDON, Oct 16- U.S. health regulators declined to approve a fixed-dose diabetes drug combination from AstraZeneca, delaying its launch and dealing a blow to an important plank of the drugmaker's business. Last year, during its defence against a $118 billion takeover attempt by Pfizer, AstraZeneca predicted the saxagliptin and dapagliflozin fixed-dose...
U.S. stocks closed mildly higher Monday in low volume trade as investors readied for the first major earnings reports due Tuesday.
Jim Cramer thinks the market is setting up to give investors an opportunity to buy these winners.
Monday was quiet, but as corporate earnings reporting ramps up, here's what to keep your eye on.
Jim Cramer outlines why the sell-off in Eli Lilly does not make sense. Time to take advantage of a pullback opportunity?
The "Fast Money" traders give their final thoughts of the day.
*EMC shares rise after Dell offer. The Dow rose for a seventh straight session, led by gains in UnitedHealth Group, which rose 2.7 percent at $122.51. This week brings results from some top U.S. banks, among other companies, and investors are eyeing a projected 4.8 percent year-over-year decline in third-quarter S&P 500 earnings, according to Thomson Reuters data.
The same drug development news that's hurting Eli Lilly shares might be good for Amgen and Sanofi-Regeneron.
*EMC shares rise after Dell offer. Oct 12- Gains in utility stocks offset a retreat in energy shares on Monday, leaving U.S. stocks near flat as investors remained nervous about third-quarter corporate results. Trading in equities was also affected by the closing of the bond market, banks and the government, including the Securities and Exchange Commission, for...
*EMC shares rise after Dell offer; VMware falls. Trading in equities was also affected by the closure of the bond market, banks and the government, including Securities and Exchange Commission, for the Columbus Day holiday. JPMorgan reports on Tuesday, with Goldman Sachs, Bank of America, Wells Fargo and Citigroup posting results through the week.
NEW YORK, Oct 12- The U.S. dollar fell on Monday and gold continued to rise as markets priced the possibility that the Federal Reserve would not begin a tightening cycle this year, while U.S. stocks opened little changed. Speaking at the annual autumn meeting of the IMF and World Bank in Lima, Peru on Sunday, Federal Reserve vice-chairman, Stanley Fischer, said...